デフォルト表紙
市場調査レポート
商品コード
1760744

ウェルネス・ゲノミクスの世界市場レポート 2025年

Wellness Genomics Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
ウェルネス・ゲノミクスの世界市場レポート 2025年
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウェルネス・ゲノミクス市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.6%で94億6,000万米ドルに成長します。予測期間中の成長は、検査の低価格化、ヘルスケア投資の拡大、個別化栄養への関心の高まり、可処分所得の増加、高齢者人口の増加、個別化された健康とウェルネスへの需要の高まりに起因すると考えられます。予測期間における主な動向には、シーケンス技術の進歩、洞察のためのAI統合、多遺伝子リスク開発、DTCプラットフォームの進歩、デジタルヘルス統合、技術提携の加速などがあります。

個別化医療に対する需要の高まりは、今後数年間のウェルネス・ゲノミクス市場の拡大を促進すると予想されます。個別化医療とは、より正確で効果的な結果を得るために、個人の特定の遺伝子プロファイル、ライフスタイル、健康状態に基づいて治療やケアをカスタマイズするヘルスケアアプローチです。遺伝子技術の進歩により、個人固有の遺伝子構成に合わせたより正確な治療計画が可能になり、標的を絞った効率的な治療が実現するため、この需要は増加しています。ウェルネス・ゲノミクスは、個人の生物学的特徴に基づき、個別化されたライフスタイルや予防的健康戦略を導く遺伝学的洞察を提供することで、個別化医療に貢献しています。例えば、2024年2月、米国の非営利団体である個別化医療連合(Personalized Medicine Coalition)は、2023年にFDAが希少疾患患者向けに16の新しい個別化治療を承認したと報告しました。その結果、個別化医療に対する需要の高まりがウェルネス・ゲノミクス市場の成長を後押ししています。

ウェルネス・ゲノミクス分野の主要企業は、遺伝子データに基づいてカスタマイズされた健康インサイトやライフスタイルガイダンスを提供するパーソナライズド・ゲノミクス・プラットフォームなどの革新的ソリューションの開発に注力しています。パーソナライズド・ゲノミクス・プラットフォームとは、個人の遺伝情報を解釈し、オーダーメイドの健康提案を提供するサービスや技術を指します。例えば、2024年9月、インドを拠点とする診断プロバイダーであるNeuberg Diagnostics Private Limitedは、遺伝子解析を用いて個々人に合わせた健康洞察を生み出すよう設計されたパーソナライズド・ゲノミクス・プラットフォームであるGenieeを発表しました。Genieeは広範な遺伝子検査を提供し、自分の遺伝子が薬、栄養、運動、食事に対する反応にどのように影響するかを個人が理解するのを助ける。この情報により、ユーザーはカスタマイズされたウェルネス戦略、早期のリスク特定、より良い治療オプションを通じて健康を改善することができます。このプラットフォームは、ユーザーが自分の健康を管理できるように設計されており、個別化医療と予防医療における重要な進歩を象徴しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界ウェルネス・ゲノミクス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のウェルネス・ゲノミクス市場:成長率分析
  • 世界のウェルネス・ゲノミクス市場の実績:規模と成長, 2019-2024
  • 世界のウェルネス・ゲノミクス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界ウェルネス・ゲノミクス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のウェルネス・ゲノミクス市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 予測テスト
  • 消費者ゲノミクス
  • その他のタイプ
  • 世界のウェルネス・ゲノミクス市場設定タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 消費者直販(DTC)
  • プロ
  • 世界のウェルネス・ゲノミクス市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 乳がん・卵巣がん検診
  • 糖尿病スクリーニングとモニタリング
  • 大腸がん検診
  • アルツハイマー病
  • 前立腺がん検診
  • 整形外科および筋骨格スクリーニング
  • その他の用途
  • 世界のウェルネス・ゲノミクス市場予測テストの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 栄養ゲノミクス検査
  • フィットネスゲノム検査
  • 疾患感受性試験
  • 世界のウェルネス・ゲノミクス市場消費者ゲノミクスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 祖先と遺産の分析
  • 個人特性分析
  • 消費者直販(DTC)ウェルネスキット
  • 世界のウェルネス・ゲノミクス市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • エピジェネティック検査
  • マイクロバイオームと腸の健康ゲノミクス
  • ライフスタイル薬のための薬理ゲノム学

第7章 地域別・国別分析

  • 世界のウェルネス・ゲノミクス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のウェルネス・ゲノミクス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ウェルネス・ゲノミクス市場:競合情勢
  • ウェルネス・ゲノミクス市場:企業プロファイル
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • 23andMe Holding Co.
  • Color Health Inc.
  • Variantyx Inc.
  • Segterra Inc.
  • Dante Labs Inc.
  • Pathway Genomics Corporation
  • NMC Healthcare LLC
  • Futura Genetics Ltd.
  • Genopalate Inc.
  • OhMyGene Inc.
  • Rootine Labs Inc.
  • Tania Flack Naturopath
  • Toolbox Genomics Inc.
  • Xcode Life Sciences Pvt. Ltd.
  • GenepoweRx Healthcare Pvt. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ウェルネス・ゲノミクス市場2029:新たな機会を提供する国
  • ウェルネス・ゲノミクス市場2029:新たな機会を提供するセグメント
  • ウェルネス・ゲノミクス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35621

Wellness genomics involves utilizing an individual's genetic data to offer tailored guidance for enhancing health, nutrition, fitness, and overall well-being. Its objective is to improve lifestyle decisions and prevent illness by examining genetic tendencies beyond the scope of traditional medical genetics.

The primary types of wellness genomics include predictive testing, consumer genomics, and others. Predictive testing refers to a genetic assessment used to identify whether an individual without symptoms carries a gene variant that could lead to a future illness. This testing is applied in multiple contexts, such as direct-to-consumer (DTC) and professional settings, and serves numerous purposes including screening for breast and ovarian cancer, diabetes monitoring, colon cancer, Alzheimer's disease, prostate cancer, orthopedic and musculoskeletal conditions, among others.

The wellness genomics market research report is one of a series of new reports from The Business Research Company that provides wellness genomics market statistics, including wellness genomics industry global market size, regional shares, competitors with a wellness genomics market share, detailed wellness genomics market segments, market trends and opportunities, and any further data you may need to thrive in the wellness genomics industry. This wellness genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wellness genomics market size has grown rapidly in recent years. It will grow from $4.99 billion in 2024 to $5.68 billion in 2025 at a compound annual growth rate (CAGR) of 13.8%. The growth during the historic period can be credited to the rising prevalence of chronic diseases, heightened consumer awareness about health, increased demand for personalized healthcare, a stronger emphasis on preventive healthcare, and the expansion of direct-to-consumer genomics.

The wellness genomics market size is expected to see rapid growth in the next few years. It will grow to $9.46 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to increasing affordability of testing, growing healthcare investments, increasing personalized nutrition interest, increasing disposable incomes, a growing geriatric population, and growing demand for personalized health and wellness. Major trends in the forecast period include advancements in sequencing tech, AI integration for insights, polygenic risk developments, DTC platform advancements, digital health integration, and tech partnerships acceleration.

The growing demand for personalized medicine is expected to drive the expansion of the wellness genomics market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and care based on an individual's specific genetic profile, lifestyle, and health conditions to achieve more accurate and effective outcomes. This demand is increasing as advancements in genetic technologies allow for more precise treatment plans tailored to an individual's unique genetic makeup, resulting in targeted and efficient therapies. Wellness genomics contributes to personalized medicine by offering genetic insights that guide personalized lifestyle and preventive health strategies based on individual biology. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare disease patients in 2023, more than double the six approved in 2022. As a result, the rising demand for personalized medicine is boosting the growth of the wellness genomics market.

Leading companies in the wellness genomics sector are concentrating on the development of innovative solutions, such as personalized genomics platforms, to deliver customized health insights and lifestyle guidance based on genetic data. A personalized genomics platform refers to a service or technology that interprets an individual's genetic information to provide tailored health recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostics provider, introduced Geniee, a personalized genomics platform designed to generate individualized health insights using genetic analysis. Geniee delivers extensive genetic testing to help individuals understand how their genes affect responses to medications, nutrition, exercise, and diet. This information enables users to improve their health through customized wellness strategies, early risk identification, and better treatment options. The platform is designed to empower users to take charge of their health, representing a significant advancement in personalized medicine and preventive care.

In September 2023, InformedDNA, a US-based precision health firm, acquired gWell Health for an undisclosed sum. The acquisition is intended to merge gWell's personalized wellness technology with InformedDNA's expertise in clinical genetics, broadening the application of precision healthcare in areas such as oncology, drug metabolism, and maternity care. It also aims to make genomic-guided health decisions more widely accessible. gWell Health, a US-based digital wellness company, specializes in applying genomics to develop personalized wellness programs.

Major players in the wellness genomics market are Danaher Corporation, Eurofins Scientific SE, BGI Group, Agilent Technologies Inc., Bio-Rad Laboratories Inc., 23andMe Holding Co., Color Health Inc., Variantyx Inc., Segterra Inc., Dante Labs Inc., Pathway Genomics Corporation, NMC Healthcare LLC, Futura Genetics Ltd., Genopalate Inc., OhMyGene Inc., Rootine Labs Inc., Tania Flack Naturopath, Toolbox Genomics Inc., and Xcode Life Sciences Pvt. Ltd., GenepoweRx Healthcare Pvt. Ltd., Gx Sciences Inc., and Nebula Genomics Inc.

North America was the largest region in the wellness genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in wellness genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the wellness genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wellness genomics market consists of revenues earned by entities providing services such as genetic testing, personalized nutrition analysis, fitness and wellness recommendations, disease risk assessment, ancestry and trait analysis, and preventive healthcare insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The wellness genomics market also includes sales of genetic testing kits, bioinformatics software, personalized health reports, and nutrigenomics supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wellness Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wellness genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wellness genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The wellness genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Predictive Testing; Consumer Genomics; Other Types
  • 2) By Setting Type: Direct-To Consumer (DTC); Professional
  • 3) By Application: Breast And Ovarian Cancer Screening; Diabetic Screening And Monitoring; Colon Cancer Screening; Alzheimer's Disease; Prostate Cancer Screening; Orthopedic And Musculoskeletal Screening; Other Applications
  • Subsegments:
  • 1) By Predictive Testing: Nutrigenomics Testing; Fitness Genomics Testing; Disease Susceptibility Testing
  • 2) By Consumer Genomics: Ancestry And Heritage Analysis; Personal Trait Analysis; Direct-To-Consumer (DTC) Wellness Kits
  • 3) By Other Types: Epigenetic Testing; Microbiome And Gut Health Genomics; Pharmacogenomics For Lifestyle Drugs
  • Companies Mentioned: Danaher Corporation; Eurofins Scientific SE; BGI Group; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wellness Genomics Market Characteristics

3. Wellness Genomics Market Trends And Strategies

4. Wellness Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Wellness Genomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wellness Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wellness Genomics Market Growth Rate Analysis
  • 5.4. Global Wellness Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wellness Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wellness Genomics Total Addressable Market (TAM)

6. Wellness Genomics Market Segmentation

  • 6.1. Global Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Consumer Genomics
  • Other Types
  • 6.2. Global Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct-To Consumer (DTC)
  • Professional
  • 6.3. Global Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast And Ovarian Cancer Screening
  • Diabetic Screening And Monitoring
  • Colon Cancer Screening
  • Alzheimer's Disease
  • Prostate Cancer Screening
  • Orthopedic And Musculoskeletal Screening
  • Other Applications
  • 6.4. Global Wellness Genomics Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nutrigenomics Testing
  • Fitness Genomics Testing
  • Disease Susceptibility Testing
  • 6.5. Global Wellness Genomics Market, Sub-Segmentation Of Consumer Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ancestry And Heritage Analysis
  • Personal Trait Analysis
  • Direct-To-Consumer (DTC) Wellness Kits
  • 6.6. Global Wellness Genomics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epigenetic Testing
  • Microbiome And Gut Health Genomics
  • Pharmacogenomics For Lifestyle Drugs

7. Wellness Genomics Market Regional And Country Analysis

  • 7.1. Global Wellness Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wellness Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wellness Genomics Market

  • 8.1. Asia-Pacific Wellness Genomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wellness Genomics Market

  • 9.1. China Wellness Genomics Market Overview
  • 9.2. China Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wellness Genomics Market

  • 10.1. India Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wellness Genomics Market

  • 11.1. Japan Wellness Genomics Market Overview
  • 11.2. Japan Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wellness Genomics Market

  • 12.1. Australia Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wellness Genomics Market

  • 13.1. Indonesia Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wellness Genomics Market

  • 14.1. South Korea Wellness Genomics Market Overview
  • 14.2. South Korea Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wellness Genomics Market

  • 15.1. Western Europe Wellness Genomics Market Overview
  • 15.2. Western Europe Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wellness Genomics Market

  • 16.1. UK Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wellness Genomics Market

  • 17.1. Germany Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wellness Genomics Market

  • 18.1. France Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wellness Genomics Market

  • 19.1. Italy Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wellness Genomics Market

  • 20.1. Spain Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wellness Genomics Market

  • 21.1. Eastern Europe Wellness Genomics Market Overview
  • 21.2. Eastern Europe Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wellness Genomics Market

  • 22.1. Russia Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wellness Genomics Market

  • 23.1. North America Wellness Genomics Market Overview
  • 23.2. North America Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wellness Genomics Market

  • 24.1. USA Wellness Genomics Market Overview
  • 24.2. USA Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wellness Genomics Market

  • 25.1. Canada Wellness Genomics Market Overview
  • 25.2. Canada Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wellness Genomics Market

  • 26.1. South America Wellness Genomics Market Overview
  • 26.2. South America Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wellness Genomics Market

  • 27.1. Brazil Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wellness Genomics Market

  • 28.1. Middle East Wellness Genomics Market Overview
  • 28.2. Middle East Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wellness Genomics Market

  • 29.1. Africa Wellness Genomics Market Overview
  • 29.2. Africa Wellness Genomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wellness Genomics Market, Segmentation By Setting Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wellness Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wellness Genomics Market Competitive Landscape And Company Profiles

  • 30.1. Wellness Genomics Market Competitive Landscape
  • 30.2. Wellness Genomics Market Company Profiles
    • 30.2.1. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Wellness Genomics Market Other Major And Innovative Companies

  • 31.1. 23andMe Holding Co.
  • 31.2. Color Health Inc.
  • 31.3. Variantyx Inc.
  • 31.4. Segterra Inc.
  • 31.5. Dante Labs Inc.
  • 31.6. Pathway Genomics Corporation
  • 31.7. NMC Healthcare LLC
  • 31.8. Futura Genetics Ltd.
  • 31.9. Genopalate Inc.
  • 31.10. OhMyGene Inc.
  • 31.11. Rootine Labs Inc.
  • 31.12. Tania Flack Naturopath
  • 31.13. Toolbox Genomics Inc.
  • 31.14. Xcode Life Sciences Pvt. Ltd.
  • 31.15. GenepoweRx Healthcare Pvt. Ltd.

32. Global Wellness Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wellness Genomics Market

34. Recent Developments In The Wellness Genomics Market

35. Wellness Genomics Market High Potential Countries, Segments and Strategies

  • 35.1 Wellness Genomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wellness Genomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wellness Genomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer